IL160875A0 - The use of botulinus toxin for the manufacture of a medicament and a cosmetic - Google Patents

The use of botulinus toxin for the manufacture of a medicament and a cosmetic

Info

Publication number
IL160875A0
IL160875A0 IL16087502A IL16087502A IL160875A0 IL 160875 A0 IL160875 A0 IL 160875A0 IL 16087502 A IL16087502 A IL 16087502A IL 16087502 A IL16087502 A IL 16087502A IL 160875 A0 IL160875 A0 IL 160875A0
Authority
IL
Israel
Prior art keywords
cosmetic
medicament
manufacture
botulinus toxin
botulinus
Prior art date
Application number
IL16087502A
Other languages
English (en)
Original Assignee
Marc Heckmann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marc Heckmann filed Critical Marc Heckmann
Publication of IL160875A0 publication Critical patent/IL160875A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16087502A 2001-09-21 2002-09-23 The use of botulinus toxin for the manufacture of a medicament and a cosmetic IL160875A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10146647A DE10146647A1 (de) 2001-09-21 2001-09-21 Arzneimittel zur Prophylaxe und Therapie von Bromhidrosis
PCT/DE2002/003561 WO2003026602A2 (de) 2001-09-21 2002-09-23 Arzneimittel zur prophylaxe und therapie von bromhidrosis

Publications (1)

Publication Number Publication Date
IL160875A0 true IL160875A0 (en) 2004-08-31

Family

ID=7699852

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16087502A IL160875A0 (en) 2001-09-21 2002-09-23 The use of botulinus toxin for the manufacture of a medicament and a cosmetic
IL160875A IL160875A (en) 2001-09-21 2004-03-15 Use of botulinum toxin for the manufacture of a medicament and a cosmetic for treating body odors

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL160875A IL160875A (en) 2001-09-21 2004-03-15 Use of botulinum toxin for the manufacture of a medicament and a cosmetic for treating body odors

Country Status (16)

Country Link
US (1) US20050036966A1 (uk)
EP (2) EP2987483B1 (uk)
JP (1) JP4966478B2 (uk)
KR (1) KR100796243B1 (uk)
CN (1) CN1289061C (uk)
AU (1) AU2002349268B2 (uk)
CA (1) CA2461117C (uk)
DE (1) DE10146647A1 (uk)
EA (2) EA008146B1 (uk)
HU (1) HU230398B1 (uk)
IL (2) IL160875A0 (uk)
MX (1) MXPA04002614A (uk)
PL (1) PL209639B1 (uk)
UA (1) UA78718C2 (uk)
WO (1) WO2003026602A2 (uk)
ZA (1) ZA200402123B (uk)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030113349A1 (en) 2001-12-18 2003-06-19 Coleman William P. Topically applied clostridium botulinum toxin compositions and treatment methods
EP1545207B1 (en) 2002-08-19 2018-03-14 Ira Sanders Treatment of holocrine gland dysfunction with clostridia neurotoxins
WO2004078199A1 (en) 2003-03-06 2004-09-16 Botulinum Toxin Research Associates, Inc. Treatment of chronic chalazion and hordeolum with botulinum toxin
US8048423B2 (en) * 2003-12-09 2011-11-01 Allergan, Inc. Botulinum toxin therapy for skin disorders
ZA200707352B (en) * 2005-03-03 2009-04-29 Revance Therapeutics Inc Compositions and methods for topical application and transdermal delivery of botulinum toxins
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
JP2010528981A (ja) 2006-12-01 2010-08-26 アンテリオス， インコーポレイテッド 両親媒性実体ナノ粒子
BRPI0914630A2 (pt) * 2008-06-26 2019-09-24 Anterios Inc liberação dérmica
US8454975B1 (en) * 2010-01-11 2013-06-04 Elizabeth VanderVeer Method for enhancing skin appearance
WO2018093465A1 (en) 2016-11-21 2018-05-24 Eirion Therapeutics, Inc. Transdermal delivery of large agents
EP3843777A4 (en) 2018-08-28 2022-05-04 Ira Sanders THERAPEUTICS FOR THE SKIN

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19852981A1 (de) * 1998-11-17 2000-05-18 Martin Schmidt Botulinum-Toxine, deren Derivate, Analoge und molekulare Bruchstücke zur topischen epicutanen Anwendung auch in Zusammenwirken mit hautpenetrationsfördernden Substanzen und Maßnahmen in Zubereitungsformen zur Beeinflussung acetylcholinabhängiger Körperfunktionen
US20020086036A1 (en) * 2000-12-05 2002-07-04 Allergan Sales, Inc. Methods for treating hyperhidrosis
US20030113349A1 (en) * 2001-12-18 2003-06-19 Coleman William P. Topically applied clostridium botulinum toxin compositions and treatment methods

Also Published As

Publication number Publication date
HU230398B1 (hu) 2016-04-28
UA78718C2 (en) 2007-04-25
IL160875A (en) 2010-11-30
EP1427385B1 (de) 2015-09-23
EP2987483A1 (de) 2016-02-24
JP4966478B2 (ja) 2012-07-04
CA2461117C (en) 2009-12-08
CA2461117A1 (en) 2003-04-03
JP2005507888A (ja) 2005-03-24
CN1289061C (zh) 2006-12-13
CN1556693A (zh) 2004-12-22
EP1427385A2 (de) 2004-06-16
EA200601238A1 (ru) 2007-06-29
KR20040048895A (ko) 2004-06-10
PL209639B1 (pl) 2011-09-30
PL373528A1 (en) 2005-09-05
US20050036966A1 (en) 2005-02-17
EA011988B1 (ru) 2009-06-30
WO2003026602A2 (de) 2003-04-03
EP2987483B1 (de) 2020-12-02
HUP0401913A3 (en) 2008-02-28
MXPA04002614A (es) 2005-02-17
DE10146647A1 (de) 2003-04-24
KR100796243B1 (ko) 2008-01-21
WO2003026602A3 (de) 2003-08-28
EA200400436A1 (ru) 2007-02-27
ZA200402123B (en) 2004-10-04
AU2002349268B2 (en) 2007-12-13
HUP0401913A2 (hu) 2005-01-28
EA008146B1 (ru) 2007-04-27

Similar Documents

Publication Publication Date Title
EP1367060A4 (en) GLUCOPYRANOSYLOXYBENZYLBENZENE DERIVATIVES AND THEIR MEDICAL USE
EP1364957A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND THEIR MEDICAL USE
EP1364958A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND MEDICINAL USE THEREOF
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
AU2002234643A1 (en) Amphoteric liposomes and the use thereof
MXPA03004936A (es) Compuestos ciclicos fusionados y uso medicinal de los mismos.
AU2001277741A1 (en) 2-aminopyridine compounds and use thereof as drugs
AU2001277731A1 (en) Fused bicyclic amide compounds and medicinal use thereof
AU2002213357A1 (en) Variant igg3 rituxan r and therapeutic use thereof
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
EP1257255A4 (en) THERAPEUTIC PRODUCT, ITS USE AND MANUFACTURE
HK1069385A1 (en) Heterocyclic compound and medicinal use thereof
IL160780A0 (en) USE OF hCG IN THE MANUFACTURE OF A MEDICAMENT
HUP0300334A3 (en) Pharmaceutical preparations and their manufacture
SI1462455T1 (sl) Ser-Ser-Ser-Arg Peptid in zdravilna uporaba le-tega
IL160875A0 (en) The use of botulinus toxin for the manufacture of a medicament and a cosmetic
HK1064042A1 (en) Medicines and medicinal kits
GB0119025D0 (en) Compounds and their therapeutic use
AU2001241875A1 (en) Human dynamin 40322
IL162507A (en) Use of ifnar2 mutants in the manufacture of medicaments
GB0018887D0 (en) Compound and their therapeutic use
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2001272552A1 (en) Oxygen-enriched agent and the use thereof for therapeutic purposes
GB0024517D0 (en) Use of medicaments
GB2376943B (en) Compounds and their therapeutic use